Leticia Campo

4.2k total citations
47 papers, 2.5k citations indexed

About

Leticia Campo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Leticia Campo has authored 47 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 21 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Leticia Campo's work include Cancer, Hypoxia, and Metabolism (19 papers), Angiogenesis and VEGF in Cancer (8 papers) and Ultrasound and Hyperthermia Applications (4 papers). Leticia Campo is often cited by papers focused on Cancer, Hypoxia, and Metabolism (19 papers), Angiogenesis and VEGF in Cancer (8 papers) and Ultrasound and Hyperthermia Applications (4 papers). Leticia Campo collaborates with scholars based in United Kingdom, Australia and Italy. Leticia Campo's co-authors include Adrian L. Harris, Helen Turley, Stephen B. Fox, Kevin C. Gatter, Francesco Pezzella, Giovanni Allevi, Simone Bonardi, Daniele Generali, Alberto Bottini and Sergio Aguggini and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Leticia Campo

45 papers receiving 2.4k citations

Peers

Leticia Campo

ONCOL

IMMUN

PRM

Olav Engebraaten Norway

Gaspar J. Kitange United States

Barbara Muz United States

Nor Eddine Sounni Belgium

Jasgit C. Sachdev United States

Nicolas Skuli United States

Ranjit S. Bindra United States

Jiha Kim United States

Hira Lal Goel United States

Tomonori Tanei Japan

Olav Engebraaten Norway

Leticia Campo

1.3k ×1.0

700 ×0.6

925 ×1.2

ONCOL

331 ×1.1

IMMUN

294 ×1.0

PRM

Citations per year, relative to Leticia Campo Leticia Campo (= 1×) peers Olav Engebraaten

Countries citing papers authored by Leticia Campo

Since Specialization

Citations

This map shows the geographic impact of Leticia Campo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leticia Campo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leticia Campo more than expected).

Fields of papers citing papers by Leticia Campo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leticia Campo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leticia Campo. The network helps show where Leticia Campo may publish in the future.

Co-authorship network of co-authors of Leticia Campo

This figure shows the co-authorship network connecting the top 25 collaborators of Leticia Campo. A scholar is included among the top collaborators of Leticia Campo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leticia Campo. Leticia Campo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barberis, Alessandro, Clemens Lang, Guillaume Rieunier, et al.. (2025). IGF-1 regulates cancer cell immune evasion in prostate cancer. Scientific Reports. 15(1). 38422–38422.

Binks, Sophie, Martı́ Pumarola, Alexandros Hardas, et al.. (2024). Gliosarcoma associated with bilateral hippocampal sclerosis in a cat presenting complex partial seizures with orofacial involvement: A case report. SHILAP Revista de lepidopterología. 12(9).

Brown, Elizabeth, Adam P. Cribbs, Martin Philpott, et al.. (2024). PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo. Scientific Reports. 14(1). 328–328. 4 indexed citations

Cheng, Vinton W.T., Nick de Pennington, Rasheed Zakaria, et al.. (2022). VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface. Clinical Cancer Research. 28(11). 2385–2396. 16 indexed citations

Fane, Mitchell E., Brett L. Ecker, Amanpreet Kaur, et al.. (2020). sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients. Clinical Cancer Research. 26(21). 5709–5719. 22 indexed citations

Craig, Stephanie G., Victoria Bingham, Matthew P. Humphries, et al.. (2020). A robust multiplex immunofluorescence and digital pathology workflow for the characterisation of the tumour immune microenvironment. Molecular Oncology. 14(10). 2384–2402. 69 indexed citations

Gray, Michael, Paul Lyon, Christophoros Mannaris, et al.. (2019). Focused Ultrasound Hyperthermia for Targeted Drug Release from Thermosensitive Liposomes: Results from a Phase I Trial. Radiology. 291(1). 232–238. 82 indexed citations

Freedman, Joshua D., Margaret R. Duffy, Janet Lei-Rossmann, et al.. (2018). An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells. Cancer Research. 78(24). 6852–6865. 135 indexed citations

Eyre, Toby A., Graham P. Collins, Avinash Gupta, et al.. (2018). A phase 1 study to assess the safety, tolerability, and pharmacokinetics of CXD101 in patients with advanced cancer. Cancer. 125(1). 99–108. 16 indexed citations

10.

Biswas, Swethajit, Philip J.S. Charlesworth, Gareth D. H. Turner, et al.. (2012). CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC. Carcinogenesis. 33(9). 1717–1725. 46 indexed citations

11.

Jubb, Adrian M., Lisa Browning, Leticia Campo, et al.. (2012). Expression of vascular Notch ligands Delta‐like 4 and Jagged‐1 in glioblastoma. Histopathology. 60(5). 740–747. 45 indexed citations

12.

Generali, Daniele, Gaynor J. Bates, Maria Pia Brizzi, et al.. (2009). Immunomodulation of FOXP3+ Regulatory T Cells by the Aromatase Inhibitor Letrozole in Breast Cancer Patients. Clinical Cancer Research. 15(3). 1046–1051. 129 indexed citations

13.

Tan, Ern Yu, Leticia Campo, Chengcheng Han, et al.. (2009). The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy. British Journal of Cancer. 100(2). 405–411. 165 indexed citations

14.

Ord, Jonathan, Sachin Agrawal, Thomas Paulraj Thamboo, et al.. (2007). An Investigation Into the Prognostic Significance of Necrosis and Hypoxia in High Grade and Invasive Bladder Cancer. The Journal of Urology. 178(2). 677–682. 49 indexed citations

15.

Generali, Daniele, Stephen B. Fox, Alfredo Berruti, et al.. (2007). Regulation of Hepatocyte Growth Factor Activator Inhibitor 2 by Hypoxia in Breast Cancer. Clinical Cancer Research. 13(2). 550–558. 12 indexed citations

16.

Kato, Takao, Graham Steers, Leticia Campo, et al.. (2007). Prognostic significance of microvessel density and other variables in Japanese and British patients with primary invasive breast cancer. British Journal of Cancer. 97(9). 1277–1286. 10 indexed citations

17.

Shaida, Nadeem, Rosalind Launchbury, J. Boddy, et al.. (2007). Expression of BNIP3 correlates with hypoxia‐inducible factor (HIF)‐1α, HIF‐2α and the androgen receptor in prostate cancer and is regulated directly by hypoxia but not androgens in cell lines. The Prostate. 68(3). 336–343. 21 indexed citations

18.

Nikitenko, Leonid L., Leticia Campo, Helen Turley, et al.. (2006). Expression of Terminally Glycosylated Calcitonin Receptor–Like Receptor in Uterine Leiomyoma: Endothelial Phenotype and Association with Microvascular Density. Clinical Cancer Research. 12(19). 5648–5658. 9 indexed citations

19.

Boddy, J., Stephen B. Fox, Han Cheng, et al.. (2005). The Androgen Receptor Is Significantly Associated with Vascular Endothelial Growth Factor and Hypoxia Sensing via Hypoxia-Inducible Factors HIF-1a, HIF-2a, and the Prolyl Hydroxylases in Human Prostate Cancer. Clinical Cancer Research. 11(21). 7658–7663. 126 indexed citations

20.

Leek, Russell, Kate Talks, Francesco Pezzella, et al.. (2002). Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer.. PubMed. 62(5). 1326–9. 177 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact